about
Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosisMusic, music therapy and dementia: a review of literature and the recommendations of the Italian Psychogeriatric Association.Menopause and estrogen deficiency as a risk factor in dementing illness: hypothesis on the biological basis.Behavioral and neurophysiological effects of transdermal rotigotine in atypical parkinsonism.Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy.Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease.Action and Object Naming in Physiological Aging: An rTMS Study.Reality orientation therapy to delay outcomes of progression in patients with dementia. A retrospective study.Temporal lobe asymmetry in patients with Alzheimer's disease with delusionsSpecific EEG changes associated with atrophy of hippocampus in subjects with mild cognitive impairment and Alzheimer's disease.Non-pharmacological intervention for memory decline.Quantitative EEG Markers in Mild Cognitive Impairment: Degenerative versus Vascular Brain Impairment.Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.Naming ability changes in physiological and pathological agingAnalysis of grey matter in thalamus and basal ganglia based on EEG α3/α2 frequency ratio reveals specific changes in subjects with mild cognitive impairment.A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.EEG upper/low alpha frequency power ratio relates to temporo-parietal brain atrophy and memory performances in mild cognitive impairment.Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio.Anodal tDCS during face-name associations memory training in Alzheimer's patients.Anatomical Substrate and Scalp EEG Markers are Correlated in Subjects with Cognitive Impairment and Alzheimer's DiseaseReminiscence therapy in dementia: a review.Empathy and emotion recognition in semantic dementia: a case report.Face-name repetition priming in semantic dementia: a case report.Universal grammar in the frontotemporal dementia spectrum: evidence of a selective disorder in the corticobasal degeneration syndrome.Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.Prefrontal cortex rTMS enhances action naming in progressive non-fluent aphasia.Grey Matter Density Predicts the Improvement of Naming Abilities After tDCS Intervention in Agrammatic Variant of Primary Progressive Aphasia.Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training.MCI patients' EEGs show group differences between those who progress and those who do not progress to AD.Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease.Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study.Atypical dementia associated with a novel presenilin-2 mutation.An electronic memory aid to support prospective memory in patients in the early stages of Alzheimer's disease: a pilot study.Serum brain-derived neurotrophic factor levels in different neurological diseases.Volumetric differences in mapped hippocampal regions correlate with increase of high alpha rhythm in Alzheimer's diseaseGenetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.Physical complaints do not decrease linearly with increasing cognitive impairment.A prospective, multidimensional follow-up study of a geriatric hospitalised population: predictors of discharge and well-being.Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study).Inhibition of energy metabolism down-regulates the Alzheimer related presenilin 2 gene.
P50
Q28572591-A4EE84CF-8AA3-4E5A-97C0-ED31E51FFA6AQ30418646-3A40D911-1015-42FD-9E71-0261FC3C8E54Q33607450-A53CC8D5-5C61-4391-8E24-BFC41DEB19E5Q33713621-091A38D0-638E-477C-A8CD-509ADB221888Q33734770-569D68FE-7E38-40E4-9356-2A7320876AFDQ33937187-DE3EC9E5-12B5-4650-A7E4-4F9F68301F0FQ34374768-0FF5B846-F825-45E4-BD33-5F90291C4ABBQ34397422-D76DD28C-3FC3-4A52-8ABE-BBE1301D536CQ35458508-578AD820-DE2B-4B36-BEF1-13B12B394274Q35810855-CF9E4848-2EDC-4914-8A40-A02C9C6A9374Q35815934-2E647DFC-01C2-4CAD-B672-598DE2F98816Q36140952-8ECDF483-C590-4518-8870-34BF3F9D7DEAQ36141850-68C60A45-2939-4F30-97B8-5D8D802D799DQ36174949-A7CCC596-3996-4903-A6E0-249C1A5D36F9Q36466486-63B2B4C2-95B9-49F8-ACC5-7BFEBE640A3AQ36801066-A293D8C4-42A6-465F-9734-2261906320B1Q36801066-AB9A3ECF-1EEE-42D6-ABD8-7C63686C3089Q37253788-8076A276-96AC-4080-BAA2-187054CF7B45Q37365365-1B1E6905-42CA-470B-BAF6-6D2BBC2777D7Q37644810-9F44ABEC-CEF9-4BFD-8874-3344D5A89ED6Q37855550-E8E9B6B6-6476-469F-8801-FF2F0F4A8E4DQ38011301-031B4707-45FB-4405-AE4D-02A78FF86C03Q38382700-1897EFD4-B433-476D-8A67-DA3794DA4464Q38383085-9F6FBCFF-7580-4DC8-9983-9A4C26594C24Q38396046-50E192E7-FAC4-4573-AACB-D72A5CBB54EFQ38404304-B6A8D181-5B2D-4C94-8DD3-8E25A48916CCQ38474328-FC1A2C5E-21CA-42BA-B8AF-41A5F1176837Q38865501-FF799023-85D6-4132-B564-A3E25EED5983Q39302982-0EDE9F71-3203-4D6B-B049-E440BD9FEBEAQ39917759-F39940A6-B0B0-4939-8A68-D984F7013CE7Q39992104-44C8EAFC-94CC-41E1-8B0E-D422C4E60391Q40514787-E46AF766-F942-40DB-A51D-4A761CB615FFQ40542342-60E1ADC9-0640-498C-9061-259B95DCE7E7Q40608112-88EF3BEC-B2E7-4E1A-BEE3-0CB9F4484897Q41811172-C2CBC400-3A45-415B-A567-6CA62A953C2FQ42102220-808188C9-9332-4E17-832B-219B8E674646Q43222531-5240A214-D854-4D41-BCA1-29308DEA60EDQ43474457-CC1479CF-6E2C-4D5B-A44E-6F96C91A0856Q43975202-845AB034-6E46-42EE-B4B5-8FF468877B0CQ44531869-059AE379-A9C7-4759-A6E6-E9F2E489FD19
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Orazio Zanetti
@ast
Orazio Zanetti
@en
Orazio Zanetti
@es
Orazio Zanetti
@nl
Orazio Zanetti
@sl
type
label
Orazio Zanetti
@ast
Orazio Zanetti
@en
Orazio Zanetti
@es
Orazio Zanetti
@nl
Orazio Zanetti
@sl
prefLabel
Orazio Zanetti
@ast
Orazio Zanetti
@en
Orazio Zanetti
@es
Orazio Zanetti
@nl
Orazio Zanetti
@sl
P1053
K-9967-2016
P106
P1153
55198528500
7004485869
P21
P2456
P31
P3829
P496
0000-0002-5408-0048